Posts From the monthly archives: "March 2014"

For the first time we will be including clinical trial data in our updated research report, Commercial Trends for Biomarker-Based IVD Tests, and here is an early look at some data describing how biomarkers are being used in drug development. Biomarker Use by Trial Phase For clinical trials registered in 2013, biomarkers are being…(Read More)

We have recently been sharing with our investors the story around biomarkers and how they have moved from adolescence into a maturing and embedded aspect of clinical development and care. We can point to lots of market dynamics that signal this transformation, but there is perhaps no more compelling evidence for this being an enduring…(Read More)

PageLines

Real-Time COVID R&D Tracking

As COVID-19 infections continue to spread, organizations with technologies or devices that can support new drug, vaccine, or test development have a life-saving contribution to make. The Amplion Intelligence Platform can alert you to new COVID-19 trial activities in real-time and automatically match you to partners who need your unique capabilities immediately. It’s already tomorrow somewhere, so let us help you start today.  Learn More

Request Access